SMAD3 and liver dysplastic nodule: Researchers in the field showed that fenofibrate reduces inflammatory responses in DN by the inhibition of the NF-kB and transforming growth factor-β1 (TGF-β1)/SMAD family member 3 (Smad3)-signaling pathways independent of PPAR-α [97, 98].